|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases at EHA 2022 |
|||||||||||
|
|
|||||||||||
|
9 June 2022
AstraZeneca will showcase data demonstrating the Company’s commitment to redefine care in haematology at the European Hematology Association (EHA) Annual Meeting, 9 to 12 June 2022. |
|||||||||||
|